Glenn Dranoff

Head, Immuno-Oncology Research Group at Novartis International AG

Glenn Dranoff

Glenn Dranoff

Head, Immuno-Oncology Research Group at Novartis International AG

Overview
RelSci Relationships

1645

Number of Boards

4

Relationships
RelSci Relationships are individuals Glenn Dranoff likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Novartis AG

Relationship likelihood: Strong

Principal Investigator at The Ragon Institute of MGH MIT & Harvard

Relationship likelihood: Strong

Chief Digital Officer at Novartis AG

Relationship likelihood: Strong

Chief Financial Officer at Novartis AG

Relationship likelihood: Strong

Founder at Morphic Therapeutic, Inc.

Relationship likelihood: Strong

Founder at Jounce Therapeutics, Inc.

Relationship likelihood: Strong

Founder at Jounce Therapeutics, Inc.

Relationship likelihood: Strong

Director of the Program in Cellular & Molecular Medicine at The Children's Hospital Corp.

Relationship likelihood: Strong

Co-Founder at CalciMedica, Inc.

Relationship likelihood: Strong

Former Senior Investigator at Immune Disease Institute

Relationship likelihood: Strong

Paths to Glenn Dranoff
Potential Connections via
Relationship Science
You
Glenn Dranoff
Head, Immuno-Oncology Research Group at Novartis International AG
Career History
Head, Immuno-Oncology Research Group
2015 - Current

Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.

Global Head-Immuno-Oncology
Current

Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA.

Professor of Medicine
Current

Harvard Medical School (HMS) is the graduate medical school of Harvard University. It is located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts.The school was founded by John Warren on September 19, 1782, with Benjamin Waterhouse, and Aaron Dexter.

Boards & Committees
Member, Scientific Advisory Board
Current

Selecta Biosciences, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. It produces the Synthetic Vaccine Particles (SVP) platform for immune tolerance and immune stimulation. The firm's proprietary pipeline includes SVP-enabled enzyme, oncology and gene therapies. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian in 2007 and is headquartered in Watertown, MA.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$500 - $999
2012

Cancer Research Institute is a private company headquartered in New York, NY, with subsidiaries in the United States, that provides cancer immunotherapy services.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Glenn Dranoff. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Glenn Dranoff's profile does not indicate a business or promotional relationship of any kind between RelSci and Glenn Dranoff.